Skip to content
  • About
    • Expert Index
    • Editorial Board
    • Editorial Team
    • Editorial Policy
  • Contact
  • Sign up

Visit

vjneurology logo
VJDementia
Logo
  • Home (current)
  • Diseases
    Alzheimer's Disease
    Dementia with Lewy Bodies
    Huntington’s Disease Dementia
    Mild Cognitive Impairment
    Parkinson's Disease
    Vascular Dementia
    View all Diseases
  • Topics
    Diagnostics
    Biology
    Communication
    Treatment
    Care Practice
    Prevention
    View all Topics
  • Conferences
    AAIC 2020
    EAN 2020
    ARUK 2020
    ARUK 2019
    AAIC 2018
    ARUK 2018
    View all Conferences
  • Features
    • About
      • Expert Index
      • Editorial Board
      • Editorial Team
      • Editorial Policy
    • Contact
    • Sign up

Mild Cognitive Impairment

Mild cognitive impairment: biomarker counseling, diagnosis and follow-up 5:11
Mild cognitive impairment: biomarker counseling, diagnosis and follow-up
Kristian Steen Frederiksen • 26 May 2020
Diagnosing mild cognitive impairment 5:21
Diagnosing mild cognitive impairment
Kristian Steen Frederiksen • 26 May 2020
Benefits of early detection in Alzheimer’s disease 4:00
Benefits of early detection in Alzheimer’s disease
Mary Paraskevaidi • 27 Apr 2020
Future research priorities for Alzheimer’s 3:02
Future research priorities for Alzheimer’s
Bryce Mander • 25 Mar 2020
Etanercept and microglial activation in mild cognitive impairment 2:12
Etanercept and microglial activation in mild cognitive impairment
Alexander Gerhard
FINGER study future: a harmonized, global network 1:30
FINGER study future: a harmonized, global network
Alina Solomon • 20 Mar 2019
FINGER study of multidomain lifestyle interventions to prevent cognitive impairment 1:58
FINGER study of multidomain lifestyle interventions to prevent cognitive impairment
Alina Solomon • 20 Mar 2019
The promise and perils of cognitive training in dementia 6:05
The promise and perils of cognitive training in dementia
Elizabeth Stine-Morrow • 17 Jul 2017
Studying patients at risk of dementia and defining subjective cognitive decline 2:16
Studying patients at risk of dementia and defining subjective cognitive decline
Ondrej Lerch • 24 Jun 2017
Basal forebrain atrophy and elevated plasmatic homocysteine levels 3:13
Basal forebrain atrophy and elevated plasmatic homocysteine levels
Ondrej Lerch • 24 Jun 2017
Journal Pages
  • Diseases
  • Topics
  • Medicines
  • Trials
  • Conferences
  • Features
Newsletter

Receive the latest news and videos from VJDementia via email

Sign up
Contact Us

Contact us for more information

mmp logo

Magdalen Centre
The Oxford Science Park
Oxford OX4 4GA, United Kingdom

VJDementia logo
The content of VJDementia is intended for healthcare professionals
  • Cookie Policy
  • Privacy Policy
  • Terms of Use
  • Editorial Policy